Phosphoinositide 3-kinase in Health and Disease Volume 1 /

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Korporativna značnica: SpringerLink (Online service)
Drugi avtorji: Rommel, Christian. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vanhaesebroeck, Bart. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vogt, Peter K. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Elektronski eKnjiga
Jezik:English
Izdano: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2011.
Izdaja:1st ed. 2011.
Serija:Current Topics in Microbiology and Immunology, 346
Teme:
Online dostop:https://doi.org/10.1007/978-3-642-13663-4
Oznake: Označite
Brez oznak, prvi označite!